Washington Research Foundation Capital
Overview
Washington Research Foundation Capital is the investment arm of the Washington Research Foundation, focusing on early-stage investments in Washington-based companies, particularly spinouts from the state's nonprofit research institutions in the life sciences, information technology, and physical sciences sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HyperSciences, Inc. | Dec 2017 | Convertible Debt | Co-investor |
| AdaptX | Nov 2023 | Series A Extension | Co-investor |
| Talus Bio | Aug 2024 | Seed | Co-investor |
| A-Alpha Bio | Sep 2019 | Seed | Co-investor |
| BrainChild Bio, Inc. | Sep 2026 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Desney Tan
Member, Board of Directors (Chair, Startup committee)
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Washington Research Foundation Capital based?
Washington Research Foundation Capital is headquartered in Seattle, Washington, United States.
When was Washington Research Foundation Capital founded?
Washington Research Foundation Capital was founded in 1996.
How many portfolio companies does Washington Research Foundation Capital have?
Washington Research Foundation Capital has 33 portfolio companies in Caplight's dataset.
What are some companies in Washington Research Foundation Capital's portfolio?
Portfolio companies visible on Caplight include HyperSciences, Inc., AdaptX, Talus Bio, A-Alpha Bio, BrainChild Bio, Inc..
What was Washington Research Foundation Capital's most recent investment shown here?
Washington Research Foundation Capital's most recent investment in this portfolio sample was in BrainChild Bio, Inc. in 2026.
What sectors does Washington Research Foundation Capital focus on?
Washington Research Foundation Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, Energy & Sustainability, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Cybersecurity, Mobility, Transportation & Logistics, Mobility, Transportation & Logistics, Enterprise Software, Telecommunications & Networking, Energy & Sustainability, Enterprise Software, Energy & Sustainability, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Washington Research Foundation Capital focus on?
Washington Research Foundation Capital typically invests at the Early stage.
What is Washington Research Foundation Capital's AUM?
Washington Research Foundation Capital's assets under management are estimated between $50.0M and $100.0M.